Patents by Inventor Yasuyuki HIRAOKA

Yasuyuki HIRAOKA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230282008
    Abstract: An image processing method includes acquiring an image in which a cell structure having a stained vascular network structure is imaged, applying a wavelet transform to the image such that a contour image in which contours of the vascular network structure are extracted is generated, and repeatedly excluding object pixels from object boundaries recognized in the contour image such that a skeleton image in which skeletons having a line width of a predetermined number of pixels are extracted is generated.
    Type: Application
    Filed: May 15, 2023
    Publication date: September 7, 2023
    Applicant: TOPPAN Inc.
    Inventor: Yasuyuki HIRAOKA
  • Publication number: 20220411750
    Abstract: The present invention relates to a cell structure including cells containing at least hepatocytes and vascular endothelial cells, and extracellular matrix component, wherein the extracellular matrix components are disposed between the cells, and a liver sinusoidal network is provided between the cells.
    Type: Application
    Filed: November 17, 2020
    Publication date: December 29, 2022
    Applicants: TOPPAN INC., Osaka University
    Inventors: Yasuyuki HIRAOKA, Shiro KITANO, Shinji IRIE, Michiya MATSUSAKI
  • Publication number: 20220356442
    Abstract: A method of producing a three-dimensional cell structure includes producing a mixture of a cell cluster including an endothelial cell, an extracellular matrix component, and a polymer electrolyte, removing a liquid from the mixture to obtain a cell aggregate, and culturing the cell aggregate in a medium to obtain a three-dimensional cell structure with a thickness greater than 150 ?m and having a vascular network. The extracellular matrix component is collagen or a collagen analog, and the polymer electrolyte is heparin or a heparin analog having a final concentration of 0.001 mg/mL or higher in the mixture.
    Type: Application
    Filed: July 14, 2022
    Publication date: November 10, 2022
    Applicant: TOPPAN Inc.
    Inventor: Yasuyuki HIRAOKA